Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
Patients who undergo total hip replacement surgery are at greater risk of getting deep vein
thrombosis (blood clots). This study evaluates the safety, tolerability and effectiveness of
the study drug, DU-176b, in reducing the occurrence of deep vein thrombosis in patients
having total hip replacement surgery.